DRI Healthcare Trust

As of June 30, 2026, DRI Healthcare Trust carries a market capitalization of 1.01B, placing it among publicly traded companies globally. Its enterprise value stands at 1.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

DRI Healthcare Trust's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, DRI Healthcare Trust has 54.96M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 4.13, and the price-to-book ratio stands at 1.64.

These figures are as of June 30, 2026. The EV/Sales ratio of 6.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.56B versus a market cap of 1.01B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, DRI Healthcare Trust posted a negative return on equity (ROE) of -9.39, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.53, reflecting losses generated across the asset base. The company generates approximately 7.45M in revenue per employee across its workforce of 33.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, DRI Healthcare Trust recorded 2.98M in income tax expense. The company reported a pretax loss of -59.54M and -62.53M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, DRI Healthcare Trust's stock has gained approximately 24.90% over the past 52 weeks. The 50-day moving average sits at 17.76, while the 200-day moving average is 16.77.

Over the twelve months ended June 30, 2026, DRI Healthcare Trust generated 245.96M in revenue and converted that into -62.53M in net income, yielding earnings per share of -1.13.

As of June 30, 2026, DRI Healthcare Trust holds 78.28M in cash and equivalents against 623.65M in total debt, resulting in a net debt position of -78.28M.

DRI Healthcare Trust produced 172.32M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -119.91M in capital expenditures, free cash flow totaled 52.41M - equivalent to 0.95 per share.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, DRI Healthcare Trust paid dividends of 0.58 per share. The dividend payout ratio of -51.35 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 5.15, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 10.59, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to DRI Healthcare Trust shareholders.